| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Sloan Sheldon is a Chief Medical Officer at Spyre Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $614K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 8,333 | $75.00 | $624,975.00 | -100% | - | - | |
| May 1, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 78,333 | $71.50 | $5,600,701.16 | -35.1% | - | - | |
| Apr 1, 2026 | SYRE Spyre Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 7,958 | $50.00 | $397,900.00 | -100% | - | - |